![]() |
|
|
Molecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland (D.G., T.H., Y.C., L.B., J.W.) and Veterinary Resources Program, National Center for Research Resources, National Institutes of Health, Bethesda, Maryland (G.M.)
Identification of the specific muscarinic acetylcholine receptor (mAChR) subtypes mediating stimulation of salivary secretion is of considerable clinical interest. Recent pharmacological and molecular genetic studies have yielded somewhat confusing and partially contradictory results regarding the involvement of individual mAChRs in this activity. In the present study, we re-examined the roles of M1 and M3 mAChRs in muscarinic agonist-mediated stimulation of salivary secretion by using M1 and M3 receptor single-knockout (KO) mice and newly generated M1/M3 receptor double-KO mice. When applied at a low dose (1 mg/kg, s.c.), the muscarinic agonist pilocarpine showed significantly reduced secretory activity in both M1 and M3 receptor single-KO mice. However, when applied at higher doses, pilocarpine induced only modestly reduced (5 mg/kg, s.c.) or unchanged (15 mg/kg, s.c.) salivation responses, respectively, in M1 and M3 receptor single-KO mice, indicating that the presence of either M1 or M3 receptors is sufficient to mediate robust salivary output. Quantitative reverse transcriptase-polymerase chain reaction studies with salivary gland tissue showed that the inactivation of the M1 or M3 mAChR genes did not lead to significantly altered mRNA levels of the remaining mAChR subtypes. Strikingly, the sialagogue activity of pilocarpine was abolished in M1/M3 receptor double-KO mice. However, salivary glands from M1/M3 receptor double-KO mice remained responsive to stimulation by the
-adrenergic receptor agonist, (S)-isoproterenol. Taken together these studies support the concept that a mixture of M1 and M3 receptors mediates cholinergic stimulation of salivary flow.
Address correspondence to: Dr. Jürgen Wess, Molecular Signaling Section, Lab. of Bioorganic Chemistry, NIH-NIDDK, Bldg. 8A, Room B1A-05, 8 Center Drive MSC 0810, Bethesda, MD 20892-0810. E-mail: jwess{at}helix.nih.gov
This article has been cited by other articles:
![]() |
N. Origlia, N. Kuczewski, E. Aztiria, D. Gautam, J. Wess, and L. Domenici Muscarinic acetylcholine receptor knockout mice show distinct synaptic plasticity impairments in the visual cortex J. Physiol., December 15, 2006; 577(3): 829 - 840. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B. Proctor Muscarinic receptors and salivary secretion J Appl Physiol, April 1, 2006; 100(4): 1103 - 1104. [Full Text] [PDF] |
||||
![]() |
G. Tobin, A. T. Ryberg, S. Gentle, and A. V. Edwards Distribution and function of muscarinic receptor subtypes in the ovine submandibular gland J Appl Physiol, April 1, 2006; 100(4): 1215 - 1223. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Southerland, G. W. Taylor, and S. Offenbacher Diabetes and Periodontal Infection: Making the Connection Clin. Diabetes, October 1, 2005; 23(4): 171 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Xie, C. Drachenberg, M. Yamada, J. Wess, and J.-P. Raufman Cholinergic agonist-induced pepsinogen secretion from murine gastric chief cells is mediated by M1 and M3 muscarinic receptors Am J Physiol Gastrointest Liver Physiol, September 1, 2005; 289(3): G521 - G529. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kuczewski, E. Aztiria, D. Gautam, J. Wess, and L. Domenici Acetylcholine modulates cortical synaptic transmission via different muscarinic receptors, as studied with receptor knockout mice J. Physiol., August 1, 2005; 566(3): 907 - 919. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gautam, S.-J. Han, T. S. Heard, Y. Cui, G. Miller, L. Bloodworth, and J. Wess Cholinergic Stimulation of Amylase Secretion from Pancreatic Acinar Cells Studied with Muscarinic Acetylcholine Receptor Mutant Mice J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 995 - 1002. [Abstract] [Full Text] [PDF] |
||||